ShockWave Medical, Inc. (SWAV) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Medical - Devices industria. La empresa tiene su sede en Santa Clara, CA, United States. El CEO actual es Douglas E. Godshall.
SWAV tiene fecha de IPO 2019-03-07, 1,468 empleados a tiempo completo, cotiza en el NASDAQ Global Select, una capitalización de mercado de $12.57B.
ShockWave Medical, Inc. is a medical device company that develops and commercializes intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases globally. The company's product portfolio includes M5 catheters for above-the-knee peripheral artery disease, C2 catheters for coronary artery disease, and S4 catheters for below-the-knee peripheral artery disease. ShockWave Medical serves interventional cardiologists, vascular surgeons, and interventional radiologists through a network of sales representatives, managers, and distributors. Founded in 2009 and headquartered in Santa Clara, California, the company addresses critical treatment needs across multiple vascular intervention markets.
